Parameter Included: 1
-
TRIPLE TEST (TRIP) In Jaipur
The Triple Test, also known as the Triple Screen Test or Triple Marker Test, is a prenatal screening tool used to assess the risk of certain chromosomal abnormalities in a developing fetus. It is typically performed in the second trimester of pregnancy.
-
Price : ₹2200.00
Reliable, Ashirwad Hospital, Jaipur
RDCAHP
: Reliable, Ashirwad Hospital, Jaipur
Reliable, Durgapura, Jaipur
RDCDUR
: Reliable, Durgapura, Jaipur
Reliable, Shri Hospital, Jaipur
RDCSHJ
: Reliable, Shri Hospital, Jaipur
Reliable, Corporate Office
RDCCOR
: Reliable, Corporate Office
Reliable, Phcc, Jaipur
RDCPHJ
: Reliable, Phcc, Jaipur
Reliable, Agra Road, Jaipur
RDCARJ
: Reliable, Agra Road, Jaipur
Parameter Included:
1
Sample Collection
Free
Doctor Consultation
Free
Test booked
100+
Report Time
24 Hours
Fasting Time
Test Recommended
Female
Recommended age
5-99 Years
Triple Marker with Graph is a maternal screening test which provides useful information about pregnancy. This test is done during 15-20 weeks of pregnancy to assess and screen the fetus for certain birth defects. The test measures the level of three important markers in the blood, Alpha-fetoprotein (AFP), Human chorionic gonadotropin (HCG), and Estriol. The triple marker is a blood test which helps diagnose genetic disorders like Down and Edward syndrome and neural tube defects. It is also useful in identifying ectopic pregnancy, miscarriages, and multiple pregnancies. . In case of abnormal results, an amniocentesis test may be advised and sometimes a detailed ultrasound is also done to examine the fetal skull and spine.
The Triple Test measures three substances in the mother's blood:
1. Alpha-fetoprotein (AFP): High AFP levels may indicate a neural tube defect, such as spina bifida, or other abnormalities like abdominal wall defects.
2. Human chorionic gonadotropin (hCG): Abnormal hCG levels can be associated with chromosomal abnormalities, such as Down syndrome.
3. Estriol: Low levels of estriol may also suggest the presence of chromosomal abnormalities.
By measuring the levels of these substances, the Triple Test provides an assessment of the risk for certain conditions, including Down syndrome, trisomy 18 (Edwards syndrome), and neural tube defects. However, it is important to note that the Triple Test is a screening tool and not a diagnostic test. A positive result indicates an increased risk but does not definitively confirm the presence of a condition.
Based on the results of the Triple Test, further diagnostic tests, such as amniocentesis or chorionic villus sampling, may be recommended to provide a more accurate diagnosis.
The Triple Test plays an essential role in prenatal care by providing information that can help expectant parents make informed decisions about their pregnancy and consider additional testing options if necessary. It is important to discuss the test, its limitations, and potential outcomes with a healthcare professional to understand the implications fully.
